Posted by Michael Wonder on 24 Feb 2022
Government of Canada signs new COVID-19 antibody therapy agreement
23 February 2022 - The Government of Canada is committed to protecting the health and safety of everyone in Canada from COVID-19. This includes securing safe and effective drugs as they become available.
Today the Honourable Filomena Tassi, Minister of Public Services and Procurement, announced that the government has signed a new conditional agreement with AstraZeneca for 100,000 doses of its antibody therapy, Evusheld, for the prevention (pre-exposure prophylaxis) of COVID-19.
The antibody therapy is under review by Health Canada for use in specific high-risk patient populations, such as people who are immunocompromised. Health Canada is currently prioritising the review of all COVID-19 vaccines and drugs.
